Among the group’s current objectives is the analysis of the role of ADAM and ADAMTS metalloproteinases in tumour progression, and the detection of new cell surface markers in glioblastoma-initiating cells. The implementation of new methodologies for quantitative proteomic analyses, such as iTRAQ and strategies without markers, while continuing to provide services in the most recent proteomic methodologies to other research groups.

Visit the research group’s page

Centres
General Hospital
Vall d'Hebron Institute of Oncology
Serveis
Medical Oncology
Ponderació
9
Recerca
Grup de Proteòmica
Enllaç
https://vhio.net/pf/proteomics-group/

Subscribe to our newsletters and be a part of Vall d'Hebron Campus

By accepting these conditions, you are agreeing to the processing of your personal data for the provision of the services requested through this portal, and, if necessary, for any procedures required by the administrations or public bodies involved in this processing, and their subsequent inclusion in the aforementioned automated file. You may exercise your rights to access, rectification, cancellation or opposition by writing to web@vallhebron.cat, clearly stating the subject as "Exercising of Data Protection Rights".
Operated by: Vall d’Hebron University Hospital Foundation – Research Institute.
Purpose: Manage the user’s contact information.
Legitimisation: Express acceptance of the privacy policy.
Rights: To access, rectify, and delete personal information data, as well to the portability thereof and to limit and/or oppose their use.
Source: The interested party themselves.